Direct oral factor Xa inhibitors in patients with morbid obesity – Author's reply

Margarita Kushnir

doi:10.1016/S2352-3026(19)30171-1

Direct oral factor Xa inhibitors in patients with morbid obesity – Author's reply

Margarita Kushnir

Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	e447
Journal	The Lancet Haematology
Volume	6
Issue number	9
DOIs	https://doi.org/10.1016/S2352-3026(19)30171-1
State	Published - Sep 2019

ASJC Scopus subject areas

Hematology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2352-3026(19)30171-1

Cite this

@article{4cebe6655ef14b028b8385821cbc54da,

title = "Direct oral factor Xa inhibitors in patients with morbid obesity – Author's reply",

author = "Margarita Kushnir",

note = "Funding Information: I have received research funding from Janssen Pharmaceuticals.",

year = "2019",

month = sep,

doi = "10.1016/S2352-3026(19)30171-1",

language = "English (US)",

volume = "6",

pages = "e447",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "9",

}

TY - JOUR

T1 - Direct oral factor Xa inhibitors in patients with morbid obesity – Author's reply

AU - Kushnir, Margarita

N1 - Funding Information: I have received research funding from Janssen Pharmaceuticals.

PY - 2019/9

Y1 - 2019/9

UR - http://www.scopus.com/inward/record.url?scp=85071243401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071243401&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(19)30171-1

DO - 10.1016/S2352-3026(19)30171-1

M3 - Letter

C2 - 31471007

AN - SCOPUS:85071243401

SN - 2352-3026

VL - 6

SP - e447

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 9

ER -

Direct oral factor Xa inhibitors in patients with morbid obesity – Author's reply

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this